Arrowhead Pharmaceuticals Inc. (A2RR34)
Market Closed
12 Jun, 19:55
B3 B3 Primary R$
47. 62
0
0%
R$
6.86B Market Cap
- P/E Ratio
- Div Yield
2,400 Volume
-1.55 Eps
R$ 47.62
Previous Close Want to track A2RR34 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Arrowhead Pharmaceuticals Inc. (A2RR34) Statistics
Valuation metrics
Market Cap 6.86B
Enterprise value 33.24B
Trailing P/E (ttm) -
Forward P/E -
PEG ratio -
Price/Sales (ttm) -
Price/Book (mrq) 18.26
Enterprise Value/Revenue 10.66
Enterprise Value/EBITDA -33.73
Overview
Shares outstanding -
Float 122.81M
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 282
Average volume (90 days) 673
Price summary
52-Week low 10.19
52-Week high 50.32
Beta 1.29
50-Day moving average 42.78
200-Day moving average 33.91
Financials
Fiscal year
Fiscal year ends 30 Sep 2025
Most recent quarter (mrq) 30 Sep 2025
Profitability
Profit margin -0.48%
Operating margin -1.92%
Operational effectiveness
Return on assets -0.07%
Return on equity -0.42%
Income Statement
Revenue (ttm) 3.12B
Revenue per share (ttm) 0.56
Quarterly revenue growth (yoy) -0.86%
Gross profit (ttm) 3.12B
EBITDA -985.5M
Net income to common (ttm) -1.51B
Diluted EPS (ttm) -5.58
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) 8.94B
Total cash per share (mrq) 12.65
Total debt (mrq) 6.94B
Total Debt/Equity (mrq) 231.05
Current ratio (mrq) 6.23%
Book value per share (mrq) 2.74
Cash Flow
Cash flow statement -182.06M
Levered free cash flow (LFCF) -231.28M
